Literature DB >> 14550764

Cyclic AMP and tumor necrosis factor-alpha regulate CXCR4 gene expression in Schwann cells.

Patrick Küry1, Hubertus Köller, Michael Hamacher, Christiane Cornely, Birgit Hasse, Hans Werner Müller.   

Abstract

Rat peripheral nerve Schwann cells have been shown to express the alpha-chemokine receptor CXCR4 as well as the corresponding ligand stromal cell-derived factor-1 (SDF-1). We have investigated gene regulatory mechanisms acting on the expression of CXCR4 in cultured rat Schwann cells and found that receptor expression at transcript- and protein levels is directly dependent on intracellular cyclic AMP. Such increased levels of CXCR4 expression were found to be efficiently reversed by the action of tumor necrosis factor-alpha (TNFalpha). We also provide evidence that the POU box transcription factor Oct-6/SCIP is involved in the control of CXCR4 transcription. Finally, we could demonstrate that CXCR4 activation by SDF-1alpha increases the number of dying Schwann cells, indicating that this receptor/ligand interaction is modulating cell survival. Our data, therefore, suggest that in the Schwann cell lineage signal transduction cascades controlled by the activation of TNF- and CXCR4 receptors are functionally coupled.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14550764     DOI: 10.1016/s1044-7431(03)00132-5

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  10 in total

Review 1.  Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology.

Authors:  Meizhang Li; Richard M Ransohoff
Journal:  Prog Neurobiol       Date:  2007-11-26       Impact factor: 11.685

2.  The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination.

Authors:  André Heinen; David Kremer; Peter Göttle; Fabian Kruse; Birgit Hasse; Helmar Lehmann; Hans Peter Hartung; Patrick Küry
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-11       Impact factor: 11.205

Review 3.  Molecules involved in the crosstalk between immune- and peripheral nerve Schwann cells.

Authors:  Nevena Tzekova; André Heinen; Patrick Küry
Journal:  J Clin Immunol       Date:  2014-04-17       Impact factor: 8.317

4.  Early pancreatic cancer lesions suppress pain through CXCL12-mediated chemoattraction of Schwann cells.

Authors:  Ihsan Ekin Demir; Kristina Kujundzic; Paulo L Pfitzinger; Ömer Cemil Saricaoglu; Steffen Teller; Timo Kehl; Carmen Mota Reyes; Linda S Ertl; Zhenhua Miao; Thomas J Schall; Elke Tieftrunk; Bernhard Haller; Kalliope Nina Diakopoulos; Magdalena U Kurkowski; Marina Lesina; Achim Krüger; Hana Algül; Helmut Friess; Güralp O Ceyhan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-16       Impact factor: 11.205

5.  CXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy.

Authors:  Sonia K Bhangoo; Dongjun Ren; Richard J Miller; David M Chan; Matthew S Ripsch; Clarissa Weiss; Christian McGinnis; Fletcher A White
Journal:  Brain Behav Immun       Date:  2007-02-09       Impact factor: 7.217

6.  Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination.

Authors:  Nam Le; Rakesh Nagarajan; James Y T Wang; Toshiyuki Araki; Robert E Schmidt; Jeffrey Milbrandt
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-03       Impact factor: 11.205

7.  Tumor necrosis factor alpha leads to increased cell surface expression of CXCR4 in SK-N-MC cells.

Authors:  Kevin Rostasy; Gullue Gorgun; Yelena Kleyner; Anthony Garcia; Michael Kramer; Suzanne M Melanson; Jean Marie Mathys; Constantin Yiannoutsos; Paul R Skolnik; Bradford A Navia
Journal:  J Neurovirol       Date:  2005-07       Impact factor: 2.643

8.  CXCL12α/SDF-1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminals.

Authors:  Samuele Negro; Francesca Lessi; Elisa Duregotti; Paolo Aretini; Marco La Ferla; Sara Franceschi; Michele Menicagli; Elisanna Bergamin; Egle Radice; Marcus Thelen; Aram Megighian; Marco Pirazzini; Chiara M Mazzanti; Michela Rigoni; Cesare Montecucco
Journal:  EMBO Mol Med       Date:  2017-08       Impact factor: 12.137

9.  Increased chemokine signaling in a model of HIV1-associated peripheral neuropathy.

Authors:  Sonia K Bhangoo; Matthew S Ripsch; David J Buchanan; Richard J Miller; Fletcher A White
Journal:  Mol Pain       Date:  2009-08-12       Impact factor: 3.395

10.  Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors.

Authors:  Sonia Bhangoo; Dongjun Ren; Richard J Miller; Kenneth J Henry; Jayana Lineswala; Chafiq Hamdouchi; Baolin Li; Patrick E Monahan; David M Chan; Matthew S Ripsch; Fletcher A White
Journal:  Mol Pain       Date:  2007-12-12       Impact factor: 3.395

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.